Is Gina Rinehart’s 28c per share bid for Warrego Energy too good to refuse?

Nick Sundich Nick Sundich, December 9, 2022

The race for Warrego Energy (ASX:WGO) has taken yet another twist with Beach Energy (ASX:BPT) withdrawing from the race. This followed Gina Rinehart making a better bid for the company that Beach was unwilling to match. So, is it a done deal now? 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Gina Rinehart’s bid for Warrego is enough to scare Beach away

Warrego Energy owns 50% of the West Erregulla onshore gas project in the Perth Basin. The other half belongs to Strike Energy (ASX:STX), which is the sole operator. After years of speculation that it would be acquired by Strike, Beach Energy (ASX:BPT) made an unexpected bid, only to be matched by Gina Rinehart

And with Rinehart upping her bid at 28c per share (well ahead of Beach’s original 20c per share offer), Beach has withdrawn from the race. Warrego Energy told its shareholders to vote in favour of the new highest bidder – in absence of a superior proposal.

 

Is it all over now?

It would be difficult for another bidder to emerge, especially with the knowledge there would likely be a bidding war as has occurred with Beach. 

However, Strike Energy told its own shareholders earlier this week that it had upped its stake in Warrego Energy to 19.9% and was ‘considering all available strategic options’. This may not mean that it will make its own bid (although it might). 

But with a big ownership stake, it could yet have a major say in whether or not the deal is accepted by shareholders. So, stay tuned!

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Orthocell

Orthocell (ASX:OCC): All systems go for a US market roll out of its flagship Remplir nerve repair product

Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in…

how tariffs impact the stock market

Here’s how tariffs impact the stock market and its investors

Many would be wondering how tariffs impact the stock market and its investors. On ‘Liberation Day‘, the returned President Trump…

oldest companies on the ASX

What are the oldest companies on the ASX? Here are 5 of them and the secrets to their success!

In this article, we look at 5 of the oldest companies on the ASX. Now, we are not claiming these…